Main Street Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
CGH
CNB
AP
COPPSERS
Main Street Group's GILD Position: Q2 2026 in Review
Main Street Group held its Gilead Sciences (GILD) position steady in Q2 2026 at 818 shares worth $103K. The position accounts for 0.02% of the portfolio, ranked #173.
Main Street Group first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. The position peaked at $173K in Q1 2024. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Main Street Group held 818 shares of Gilead Sciences worth $103K as of Q2 2026.
- Main Street Group left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up 0.02% of Main Street Group's portfolio in Q2 2026, its #173 holding.
- Main Street Group first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
- Main Street Group's Gilead Sciences position peaked at $173K in Q1 2024.
- 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.